We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Actividentity Corp (MM) | NASDAQ:ACTI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.24 | 0 | 01:00:00 |
First quarter in brief
Events after the end of the period
Financial summary
SEK M | Jan-Mar | Full-year | |||
2019 | 2018 | 2018 | |||
Net sales | 5.5 | 4.8 | 20.1 | ||
Operating loss | -6.4 | -8.5 | -29.8 | ||
Loss after tax | -8.1 | -10.2 | -36.9 | ||
Loss per share (SEK) | -0.06 | -0.11 | -0.27 | ||
Cash and cash equivalents (at close of the period) | 16.4 | 12.8 | 25.6 |
For further information, please contact:
Helén Tuvesson, CEO Tel: +46 (0)46-19 21 56 Hans Kolam, CFO Tel: +46 (0)46 19 20 44 | Active Biotech AB (Corp. Reg. No. 556223-9227) Box 724, SE-220 07 Lund Tel: +46 (0)46-19 20 00 |
The report is also available at https://www.activebiotech.com/en.
Active Biotech is obligated to make public the information contained in this report pursuant to the EU Market Abuse Regulation. This information was provided to the media, through the agency of the contact person set out above, for publication on April 25, 2019, at 08.30 a.m. CET.
1 Year Actividentity Corp (MM) Chart |
1 Month Actividentity Corp (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions